hemotune builds a versatile magnetic nanoparticle platform that enables highly selective, efficient, and scalable separation of biomolecules from complex fluids. In medicine this means removing harmful agents directly from the bloodstream rather than adding compounds, which aims to reduce side effects and support multi‑target strategies. The same platform powers high‑value non‑therapeutic applications across the value chain.
We envision a future where capturing what matters becomes the foundation of precision medicine and advanced processes. By enabling selective removal and targeted capture, our platform aims to improve patient outcomes, empower next-generation therapies, and drive innovation across healthcare and high-value industries.
Our mission is to develop and scale a versatile magnetic nanoparticle platform that captures what matters most for every application. We strive to deliver solutions that enable new therapeutic strategies, optimize critical processes, and create lasting value for patients, partners, and society.
We are driven by impact and committed to creating meaningful outcomes for patients, partners, and society. We embrace innovation by challenging assumptions, exploring bold ideas, and striving for continuous improvement. We believe in teamwork because the best results come from collaboration, trust, and shared purpose. We act with integrity in every decision, ensuring honesty, responsibility, and transparency as the foundation of everything we do.
Founded as a spin‑off from ETH Zurich, Switzerland with the goal of redefining blood purification through magnetic nanotechnology.
Advanced the concept at Wyss Zurich, Switzerland, with interdisciplinary work across chemistry, materials science, engineering, and clinical translation.
Implemented robust development and quality practices to support clinical use and to prepare for manufacturing and integration in high‑value non‑therapeutic processes.
